119 related articles for article (PubMed ID: 1502887)
21. Fractionated locoregional low-dose radioimmunotherapy improves survival in a mouse model of diffuse-type gastric cancer using a 213Bi-conjugated monoclonal antibody.
Bloechl S; Beck R; Seidl C; Morgenstern A; Schwaiger M; Senekowitsch-Schmidtke R
Clin Cancer Res; 2005 Oct; 11(19 Pt 2):7070s-7074s. PubMed ID: 16203804
[TBL] [Abstract][Full Text] [Related]
22. Immunotargeting with monoclonal cytokeratin 8 antibodies of human urothelial cancer transplanted to nude mice.
Letocha H; Nilsson S; Silén A; Ekblom J; Arnberg H; Wiklund B; Westlin JE
Acta Oncol; 1993; 32(7-8):793-800. PubMed ID: 7508236
[TBL] [Abstract][Full Text] [Related]
23. A new animal model for hyperthermic intraperitoneal chemotherapy (HIPEC) in tumor-bearing mice in the treatment of peritoneal carcinomatosis of ovarian origin.
Miailhe G; Arfi A; Mirshahi M; Eveno C; Pocard M; Touboul C
J Visc Surg; 2018 Jun; 155(3):183-189. PubMed ID: 29108718
[TBL] [Abstract][Full Text] [Related]
24. Biodistribution of indium-111-labeled OC 125 monoclonal antibody after intraperitoneal injection in nude mice intraperitoneally grafted with ovarian carcinoma.
Thédrez P; Saccavini JC; Nolibé D; Simoen JP; Guerreau D; Gestin JF; Kremer M; Chatal JF
Cancer Res; 1989 Jun; 49(11):3081-6. PubMed ID: 2720666
[TBL] [Abstract][Full Text] [Related]
25. Tumor pretargeting for radioimmunodetection and radioimmunotherapy.
Zhu H; Jain RK; Baxter LT
J Nucl Med; 1998 Jan; 39(1):65-76. PubMed ID: 9443740
[TBL] [Abstract][Full Text] [Related]
26. Interferon-alpha-2b immunoconjugate for improving immunoscintigraphy and immunotherapy.
Pallela VR; Rao SP; Thakur ML
J Nucl Med; 2000 Jun; 41(6):1108-13. PubMed ID: 10855643
[TBL] [Abstract][Full Text] [Related]
27. Experimental radioimmunotherapy of small peritoneal metastases of colorectal origin.
Koppe MJ; Soede AC; Pels W; Oyen WJ; Goldenberg DM; Bleichrodt RP; Boerman OC
Int J Cancer; 2003 Oct; 106(6):965-72. PubMed ID: 12918078
[TBL] [Abstract][Full Text] [Related]
28. Biodistribution and dosimetric study in medullary thyroid cancer xenograft using bispecific antibody and iodine-125-labeled bivalent hapten.
Hosono M; Hosono MN; Kraeber-Bodéré F; Devys A; Thédrez P; Fiche M; Gautherot E; Barbet J; Chatal JF
J Nucl Med; 1998 Sep; 39(9):1608-13. PubMed ID: 9744353
[TBL] [Abstract][Full Text] [Related]
29. Indium-111- and yttrium-90-labeled human monoclonal immunoglobulin M targeting of human ovarian cancer in mice.
Borchardt PE; Quadri SM; Freedman RS; Vriesendorp HM
J Nucl Med; 1998 Mar; 39(3):476-84. PubMed ID: 9529295
[TBL] [Abstract][Full Text] [Related]
30. [Immunotargeting of tumors: state of the art and prospects in 2000].
Pèlegrin A; Xavier F; Barbet J; Bartholeyns J; Baty D; Buchegger F; Chatal JF; Dufief F; Gurreau D; Gruaz-Guyon A; Lamotte D; Leserman L; Mach JP; Robert B; Saccavini JC; Teillaud JL; Teulon I
Bull Cancer; 2000 Nov; 87(11):777-91. PubMed ID: 11125287
[TBL] [Abstract][Full Text] [Related]
31. Tumor targeting with radiolabeled antibodies in a human carcinoembryonic antigen transgenic mouse model.
Szalai G; Williams LE; Primus FJ
Int J Cancer; 2000 Mar; 85(6):751-6. PubMed ID: 10709090
[TBL] [Abstract][Full Text] [Related]
32. Locoregional alpha-radioimmunotherapy of intraperitoneal tumor cell dissemination using a tumor-specific monoclonal antibody.
Huber R; Seidl C; Schmid E; Seidenschwang S; Becker KF; Schuhmacher C; Apostolidis C; Nikula T; Kremmer E; Schwaiger M; Senekowitsch-Schmidtke R
Clin Cancer Res; 2003 Sep; 9(10 Pt 2):3922S-8S. PubMed ID: 14506190
[TBL] [Abstract][Full Text] [Related]
33. Radioimmunotherapy with 90Y-labeled monoclonal antibodies in a nude mouse ovarian cancer model.
Kairemo K; Ljunggren K; Strand SE; Hiltunen J; Penttilä P; Nikula T; Laine A; Wahlström T
Acta Oncol; 1993; 32(7-8):801-5. PubMed ID: 8305229
[TBL] [Abstract][Full Text] [Related]
34. 211At radioimmunotherapy of subcutaneous human ovarian cancer xenografts: evaluation of relative biologic effectiveness of an alpha-emitter in vivo.
Bäck T; Andersson H; Divgi CR; Hultborn R; Jensen H; Lindegren S; Palm S; Jacobsson L
J Nucl Med; 2005 Dec; 46(12):2061-7. PubMed ID: 16330571
[TBL] [Abstract][Full Text] [Related]
35. Monoclonal antibodies in the management of ovarian cancer. A clinical perspective.
Rubin SC
Cancer; 1993 Feb; 71(4 Suppl):1602-12. PubMed ID: 8431896
[TBL] [Abstract][Full Text] [Related]
36. Carcinoembryonic antigen as a target cancer antigen for radiolabeled antibodies: prospects for cancer imaging and therapy.
Goldenberg DM
Tumour Biol; 1995; 16(1):62-73. PubMed ID: 7863224
[TBL] [Abstract][Full Text] [Related]
37. Comparison of the therapeutic efficacy of 211At- and 131I-labelled monoclonal antibody MOv18 in nude mice with intraperitoneal growth of human ovarian cancer.
Andersson H; Palm S; Lindegren S; Bäck T; Jacobsson L; Leser G; Horvath G
Anticancer Res; 2001; 21(1A):409-12. PubMed ID: 11299770
[TBL] [Abstract][Full Text] [Related]
38. [Radioimmunoimaging of lymphoma in mice with a two-step pretargeting strategy using biotinyled CD45 monoclonal antibody and (188)Re-avidin].
Li G; Zheng W; Huang B; DU L; Qi Y; Huang K; Zhang H
Nan Fang Yi Ke Da Xue Xue Bao; 2015 Aug; 35(8):1175-9. PubMed ID: 26277517
[TBL] [Abstract][Full Text] [Related]
39. B-cell hybridoma as intraperitoneal tumor model: correlation between tumor growth and monoclonal antibody production.
Vergote I; De Vos L; Fjeld J; Nesland J; Kierulf B; Michaelsen T; Nustad K
Hybridoma; 1992 Jun; 11(3):323-31. PubMed ID: 1500068
[TBL] [Abstract][Full Text] [Related]
40. Therapy and imaging of pancreatic carcinoma xenografts with radioiodine-labeled chimeric monoclonal antibody A10 and its Fab fragment.
Kamigaki T; Yamamoto M; Ohyanagi H; Ohya M; Shimazoe T; Kono A; Ohtani W; Narita Y; Ohkubo M; Saitoh Y
Jpn J Cancer Res; 1995 Dec; 86(12):1216-23. PubMed ID: 8636013
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]